@ARTICLE{
author={Andric Zoran G,Ceric Timur,Stanetic Mirko,Rancic Milan H,Jakopovic Marko,Aix S Ponce,Ramlau Rodryg,Smit E,Ulanska M,Caldwell C,Ferrari D,Annis A,Vukovic V,Zaric Bojan},
year={2020},
title={Prevention of Chemotherapy-induced Myelosuppression in SCLC patients treated with the Dual MDMX/MDM2 Inhibitor ALRN-6924},
journal={EUROPEAN JOURNAL OF CANCER},
volume={138},
number={},
pages={S5-S5},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Smit E,Reck M,Krzakowski M,Gridelli C,Curescu S,Berzinec Peter,Barata F,McDermott R,Jovanovic D,Magyarlo P},
year={2007},
title={Erlotinib in patients with advanced non-small-cell lung cancer (NSCLC): interim results from the European subpopulation of the open-label TRUST study},
journal={EJC SUPPLEMENTS},
volume={5},
number={4},
pages={359-359},
document_type={Meeting Abstract},
}